Avery Therapeutics' Debt Round

Avery Therapeutics raised a round of funding on June 01, 2017.

Avery Therapeutics is dedicated to advancing tissue-engineered therapeutics to treat diseases and injuries to human muscle. Avery's lead product, MyCardia, is a tissue-engineered heart graft developed…

Articles about Avery Therapeutics' Debt Round: